American Portfolios Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

American Portfolios Advisors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$4.59K	Hold	11	–	–	﹤0.01%	2850
2022 Q2	$5.45K	Sell	11 -14	-56%	-$7.29K	﹤0.01%	2794
2022 Q1	$14.1K	Sell	25 -103	-80%	-$62.1K	﹤0.01%	2535
2021 Q4	$96.7K	Buy	128 +104	+433%	+$77.8K	﹤0.01%	1531
2021 Q3	$17.9K	Sell	24 -1,205	-98%	-$903K	﹤0.01%	2331
2021 Q2	$792K	Buy	1,229 +160	+15%	+$97.4K	0.03%	535
2021 Q1	$611K	Buy	1,069 +1,066	+35,533%	+$631K	0.03%	578
2020 Q4	$1.75K	Sell	3 -1	-25%	-$570	﹤0.01%	2728
2020 Q3	$2.06K	Hold	4	–	–	﹤0.01%	2598
2020 Q2	$1.81K	Buy	+4	New	+$1.76K	﹤0.01%	2581
2018 Q3	–	Sell	-5	Closed	-$1.44K	–	2415
2018 Q2	$1.44K	Sell	5 -3	-38%	-$828	﹤0.01%	2233
2018 Q1	$2K	Hold	8	–	–	﹤0.01%	2106
2017 Q4	$1.91K	Buy	+8	New	+$1.94K	﹤0.01%	2061

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American Portfolios Advisors's BIO Position: Q3 2022 in Review

American Portfolios Advisors held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2022 at 11 shares worth $4.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2850.

American Portfolios Advisors first reported a position in BIO in Q4 2017 and has held it in 13 quarters since. The position peaked at $792K in Q2 2021. 486 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

American Portfolios Advisors held 11 shares of Bio-Rad Laboratories Class A worth $4.59K as of Q3 2022.
American Portfolios Advisors left its Bio-Rad Laboratories Class A share count unchanged in Q3 2022.
Bio-Rad Laboratories Class A made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2850 holding.
American Portfolios Advisors first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and has held it in 13 quarters since.
American Portfolios Advisors's Bio-Rad Laboratories Class A position peaked at $792K in Q2 2021.
486 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.